Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Herre Kingma

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Acta Orthopaedica|September 8, 2011
Complications after hip arthroplasty and the association with hospital procedure volumeLaura M de Vries, Miriam C J M Sturkenboom, Jan A N Verhaar, et al.
Pharmacy World & Science : PWS|April 17, 2004
Oral antiarrhythmic drugs in converting recent onset atrial fibrillationVera H M Deneer, Marieke B I Borgh, J Herre Kingma, et al.
American Heart Journal|April 13, 2004
Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunctionGysèle S Bleumink, Cornelia M van Duijn, J Herre Kingma, et al.
Journal of the American College of Cardiology|December 8, 2004
Drug-induced atrial fibrillationCornelis S van der Hooft, Jan Heeringa, Gerard van Herpen, et al.
Archives of Internal Medicine|May 10, 2006
Corticosteroids and the risk of atrial fibrillationCornelis S van der Hooft, Jan Heeringa, Guy G Brusselle, et al.
Journal of the American College of Cardiology|January 23, 2004
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) StudyVincent E Hagens, Adelita V Ranchor, Eric Van Sonderen, et al.
Archives of Internal Medicine|July 1, 2004
Antipsychotics and the risk of sudden cardiac deathSabine M J M Straus, Gysèle S Bleumink, Jeanne P Dieleman, et al.
Pharmacogenetics and Genomics|April 30, 2005
Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphismGysèle S Bleumink, Anna F C Schut, Miriam C J M Sturkenboom, et al.
European Heart Journal|September 3, 2004
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) studyVincent E Hagens, Karin M Vermeulen, Elisabeth M TenVergert, et al.
The New England Journal of Medicine|December 6, 2002
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillationIsabelle C Van Gelder, Vincent E Hagens, Hans A Bosker, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Orthopaedica|September 8, 2011
Complications after hip arthroplasty and the association with hospital procedure volumeLaura M de Vries, Miriam C J M Sturkenboom, Jan A N Verhaar, et al.
Pharmacy World & Science : PWS|April 17, 2004
Oral antiarrhythmic drugs in converting recent onset atrial fibrillationVera H M Deneer, Marieke B I Borgh, J Herre Kingma, et al.
American Heart Journal|April 13, 2004
Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunctionGysèle S Bleumink, Cornelia M van Duijn, J Herre Kingma, et al.
Journal of the American College of Cardiology|December 8, 2004
Drug-induced atrial fibrillationCornelis S van der Hooft, Jan Heeringa, Gerard van Herpen, et al.
Archives of Internal Medicine|May 10, 2006
Corticosteroids and the risk of atrial fibrillationCornelis S van der Hooft, Jan Heeringa, Guy G Brusselle, et al.
Journal of the American College of Cardiology|January 23, 2004
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) StudyVincent E Hagens, Adelita V Ranchor, Eric Van Sonderen, et al.
Archives of Internal Medicine|July 1, 2004
Antipsychotics and the risk of sudden cardiac deathSabine M J M Straus, Gysèle S Bleumink, Jeanne P Dieleman, et al.
Pharmacogenetics and Genomics|April 30, 2005
Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphismGysèle S Bleumink, Anna F C Schut, Miriam C J M Sturkenboom, et al.
European Heart Journal|September 3, 2004
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) studyVincent E Hagens, Karin M Vermeulen, Elisabeth M TenVergert, et al.
The New England Journal of Medicine|December 6, 2002
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillationIsabelle C Van Gelder, Vincent E Hagens, Hans A Bosker, et al.
Pageof 2